EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $791,997,000 | -65.9% | 18,644 | -61.5% | 0.01% | -73.0% |
| Q2 2020 | $2,320,888,000 | +65853.1% | 48,372 | -36.8% | 0.04% | -31.5% |
| Q1 2020 | $3,519,000 | +20.8% | 76,510 | +57.8% | 0.05% | +134.8% |
| Q4 2019 | $2,914,000 | +327.9% | 48,494 | +302.9% | 0.02% | +283.3% |
| Q3 2019 | $681,000 | -9.3% | 12,035 | -15.6% | 0.01% | +20.0% |
| Q1 2018 | $751,000 | -71.2% | 14,258 | -70.8% | 0.01% | -64.3% |
| Q4 2017 | $2,609,000 | -68.3% | 48,847 | -64.6% | 0.01% | -76.3% |
| Q3 2017 | $8,232,000 | +76.1% | 138,030 | +133.0% | 0.06% | +55.3% |
| Q2 2017 | $4,674,000 | +14.2% | 59,246 | +20.1% | 0.04% | +11.8% |
| Q1 2017 | $4,093,000 | -29.1% | 49,346 | -40.1% | 0.03% | -35.8% |
| Q3 2016 | $5,769,000 | – | 82,415 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |